Catalyst Wire Dossier Catalyst Wire Dossier

Orellanine

· Oncorena AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Orellanine, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma [Phase 1, Phase 2]

See pricing